08/13/2025
3:26 PM | Jade Biosciences, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-A12B/A | |
07/29/2025
12:46 PM | Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
07/17/2025
7:12 PM | BlackRock, Inc. (Filed by)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form SCHEDULE 13G | |
07/14/2025
6:10 PM | Dahms Bradford D. (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/14/2025
6:12 PM | Dahms Bradford D. (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
6:08 AM | Jade Biosciences, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
4:31 PM | Atlas Venture Associates XII, L.P. (Reporting)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
4:37 PM | Atlas Venture Fund XII, L.P. (Reporting)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
3:59 PM | Atlas Venture Associates XII, L.P. (Reporting)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
4:03 PM | Atlas Venture Fund XII, L.P. (Reporting)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2025
3:23 PM | Deep Track Capital, LP (Filed by)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for JBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Jade Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
9:03 AM | FMR LLC (Filed by)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form SCHEDULE 13G | |
05/05/2025
8:43 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form SCHEDULE 13G | |
05/01/2025
5:31 PM | Fairmount Funds Management LLC (Filed by)
Jade Biosciences, Inc. (Subject)
Jade Biosciences (Subject)
| Form SCHEDULE 13D | |
05/01/2025
4:44 PM | Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Klein Lawrence Otto (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:51 PM | Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Lavelle Erin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:58 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
5:00 PM | DOBMEIER ERIC (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:07 PM | CAIN CHRISTOPHER W. (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:10 PM | Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:15 PM | Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Lavelle Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:16 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
4:21 PM | Frohlich Tom (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:22 PM | Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Quick Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:27 PM | Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
King Andrew James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:30 PM | Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
Kocinsky Hetal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:32 PM | Balta Elizabeth (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:39 PM | DOBMEIER ERIC (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
4:41 PM | CAIN CHRISTOPHER W. (Reporting)
Jade Biosciences, Inc. (Issuer)
Jade Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2025
3:22 PM | Jade Biosciences, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:30 PM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
3:37 PM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
7:07 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
3:20 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
04/09/2025
6:00 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
6:01 AM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
04/07/2025
7:39 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
7:42 AM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
04/07/2025
7:46 AM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
03/27/2025
6:30 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2025
3:54 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
A Major Economic Change Is Happening Now (Ad) Louis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and earning a reputation for fact-based analysis, not sensationalism. That’s why his latest economic warning is turning so many heads.
In his new report, Louis reveals how recent policies are accelerating a massive economic shift. While headlines point to strong numbers, everyday Americans feel the squeeze as prices climb and industries are reshaped. According to Louis, this transformation could determine who falls behind — and who builds lasting wealth. Read Louis Navellier’s urgent report here |
03/25/2025
11:15 PM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form EFFECT | |
03/25/2025
3:25 PM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 424B3 | |
03/24/2025
9:45 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form S-4/A | |
03/14/2025
4:16 PM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form S-4/A | |
03/03/2025
3:45 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
02/24/2025
8:57 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form S-4/A | |
01/24/2025
3:17 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
01/22/2025
7:45 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form S-4/A | |
01/13/2025
4:24 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
12/03/2024
5:27 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
11/18/2024
4:29 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
10/31/2024
3:55 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
10/31/2024
3:57 PM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
10/31/2024
8:27 AM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:29 AM | Aerovate Therapeutics, Inc. (Subject)
Jade Biosciences (Subject)
| Form 425 | |
10/17/2024
3:59 PM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:04 PM | Aerovate Therapeutics, Inc. (Filer)
Jade Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access